Header Logo

Connection

CHAAN S NG to Salicylates

Back to Details
This is a "connection" page, showing publications CHAAN S NG has written about Salicylates.
CHAAN S NG
Connection Strength
0.090
Salicylates
  1. Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors. Cancer Chemother Pharmacol. 2010 Jan; 65(2):235-41.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.